Get the Stockscreener App
0.3965
1.80%
0.007
BiomX Inc stock is traded at $0.3965, with a volume of 244.20K.
It is up +1.80% in the last 24 hours and down -12.88% over the past month.
BiomX Inc., a clinical stage company, develops bacteriophage-based therapies for the treatment and prevention of diseases from the microbiome. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), liver, primary sclerosing cholangitis, and cancer. The company's lead product candidate BX001, which is in phase I that helps to modify the appearance of skin in various skin types, including oily and acne-prone skin type; BX002, a therapeutic phage product to treat IBD; BX003, targets bacteria associated with progressive liver disorder (PSC), a rare inflammatory liver disease; and CRC, targets strains of bacteria found in colorectal cancer tumors. The company has license agreement collaboration with The Weizmann Institute of Science to develop, test, manufacture, produce, and sell microbiome-based therapeutic product candidate; Takeda, develops formulations for phage therapy manufacturing intermediates and for the final form to be administered; Keio University and JSR Corporation, a set of bacterial targets for the development and commercialization of phage therapies to treat IBD; and Janssen Research & Development, LLC to utilize XMarker microbiome-based biomarker discovery platform. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel.
See More
Previous Close:
$0.3895
Open:
$0.39
24h Volume:
244.20K
Relative Volume:
0.23
Market Cap:
$10.38M
Revenue:
-
Net Income/Loss:
$-26.56M
P/E Ratio:
-0.61
EPS:
-0.65
Net Cash Flow:
$-22.29M
1W Performance:
-7.66%
1M Performance:
-12.88%
6M Performance:
-45.60%
1Y Performance:
-80.56%
1-Day Range:
$0.38
$0.4049
1-Week Range:
$0.3781
$0.4405
52-Week Range:
$0.34
$1.979
BiomX Inc Stock (PHGE) Company Profile
Name
BiomX Inc
Sector
Industry
Phone
972 7 23942377
Address
7 Pinhas Sapir Street, 2nd Floor, Ness Ziona
Compare PHGE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PHGE
BiomX Inc
|
0.3965 | 10.20M | 0 | -26.56M | -22.29M | -0.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
BiomX Inc Stock (PHGE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-21 | Initiated | Ladenburg Thalmann | Buy |
BiomX Inc Stock (PHGE) Latest News
What data driven models say about BiomX Inc.’s futureEquity Forecast with Predictive AI Screener - Newser
Is it time to cut losses on BiomX Inc.Chart Pattern Recognition for Profit Timing - Newser
Can BiomX Inc. hit a new high this monthAI Driven Swing Trade Forecasting Insight - Newser
Visual analytics tools that track BiomX Inc. performanceFundamental Forecast for Undervalued Stocks - Newser
Building trade automation scripts for BiomX Inc.Buy and Hold Strategy for Capital Safety - Newser
What are analysts’ price targets for BiomX Inc. in the next 12 monthsExpert Picks Review That Work - jammulinksnews.com
Why BiomX Inc. is moving todaySafe Investment Ideas with Growth Upside - Newser
Published on: 2025-07-31 22:15:40 - Newser
Why is BiomX Inc. stock attracting strong analyst attentionLow Risk Updates For Beginners - jammulinksnews.com
What is the dividend policy of BiomX Inc. stockPost Market Updates For Consistent Profits - jammulinksnews.com
What are the latest earnings results for BiomX Inc.Wealth Building Planner With Proven Results - jammulinksnews.com
BiomX Sets 2025 Annual Meeting Date - The Globe and Mail
Is BiomX Inc. stock poised for growthMulti-Bagger Detection with Trend Tools - Newser
How BiomX Inc. stock performs during market volatilityInvestment Timeline and ROI Summary Report - Newser
BiomX sets date for 2025 annual meeting and shareholder proposal deadline - Investing.com Australia
BiomX Inc. Stock Performance After Earnings: Historical InsightsBreakout Stock Opportunities with Low Drawdown - Newser
Published on: 2025-07-30 23:43:41 - Newser
Is BiomX Inc. Stock a Smart Buy in 2025 Investment Analysis InsideRisk Managed Intraday Trade Alerts Increase in Volume - metal.it
How to interpret RSI for BiomX Inc. stockVolume Confirmed Setup with Entry Confidence - Newser
Leading vs lagging indicators on BiomX Inc. performanceFree Weekly Setup With 3x Return Potential - Newser
Will BiomX Inc. price bounce be sustainableReal Market Tracker with Price Action Tools - Newser
BiomX Inc. Testing Reversal Zone on Weekly ChartMarket Momentum and Signal Alerts Suggest Reversal - beatles.ru
What are the technical indicators suggesting about BiomX Inc.Best Dividend Tracker For Every Investor - jammulinksnews.com
What institutional investors are buying BiomX Inc. stockInvest smarter with daily market updates - jammulinksnews.com
Does BiomX Inc. stock perform well during market downturnsFree Stock Market Forecast Reports - jammulinksnews.com
How strong is BiomX Inc. company’s balance sheetAchieve consistent profits with proven methods - jammulinksnews.com
How does BiomX Inc. compare to its industry peersInvest smarter and grow your wealth faster - jammulinksnews.com
When is BiomX Inc. stock expected to show significant growthBuild a diversified portfolio for stability - jammulinksnews.com
What makes BiomX Inc. stock price move sharplyFast-track wealth growth - jammulinksnews.com
What catalysts could drive BiomX Inc. stock higher in 2025Free Buy/Sell Signal Notifications - jammulinksnews.com
How many analysts rate BiomX Inc. as a “Buy”Outstanding capital growth - jammulinksnews.com
Published on: 2025-07-28 06:08:05 - jammulinksnews.com
Should I hold or sell BiomX Inc. stock in 2025Capitalize on market momentum for big wins - jammulinksnews.com
BiomX Inc Stock (PHGE) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):